Get the tools used by (smart)2 investors.
SP500 0.6%DOW 1.0%FTSE 100 0.9%NIKKEI -0.3%OIL 3.4%GOLD 1.4%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Revenue for Novartis AG ADR

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

NVS: Novartis AG ADR

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiote...

111.48 USD
Price
– USD
Fair Value
–
Upside
92.35 - 120.92
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Novartis AG ADR's Revenue:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 202435 B40 B45 B50 B55 B60 B
Performance Summary
  • Novartis AG ADR's latest twelve months revenue is 51.722 billion
  • Novartis AG ADR's revenue for fiscal years ending December 2020 to 2024 averaged 47.143 billion.
  • Novartis AG ADR's operated at median revenue of 46.66 billion from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Novartis AG ADR's revenue peaked in December 2024 at 51.722 billion.
  • Novartis AG ADR's revenue hit its 5-year low in December 2022 of 43.461 billion.
  • Novartis AG ADR's revenue decreased in 2021 (43.974 billion, -11.9%) and 2022 (43.461 billion, -1.2%) and increased in 2020 (49.898 billion, +2.5%), 2023 (46.66 billion, +7.4%), and 2024 (51.722 billion, +10.8%).

Benchmarks

Metric Usage: Revenue

Hide this widget
total_rev
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Revenue in the financials category include:

  • EBITDA - Income before interest, taxes, depreciation and amortization adjusted for certain one-time items.
  • Inventory Long-Term - This item represents the non-current inventories of the motion picture film industry comprising of certain capitalized costs incurred for the acquisition and production of entertainment properties.
  • Operating Leases, Debt Equivalent - This item represents the amount of additional capital leases on the company's balance sheet if all operating leases were capitalized.
  • Interest on Long-Term Debt - This item represents the gross amount of interest on long-term debt.
View Full List

Search for metric or datapoint

Revenue

The revenue metric captures the total income generated by a company from its core operational activities

Definition of Revenue

Hide this widget

Novartis reported revenue of 51.722 B for the latest twelve months ending December 31, 2024 on its income statement.

The tables below summarises Novartis’s Revenue over the last five years:

Fiscal Year Revenue
2020-12-31 49.898 B
2021-12-31 43.974 B
2022-12-31 43.461 B
2023-12-31 46.66 B
2024-12-31 51.722 B

The tables below summarizes Novartis’s Revenue over the last four quarters:

Quarter Ending Revenue
2024-03-31 12.12 B
2024-06-30 12.872 B
2024-09-30 13.172 B
2024-12-31 13.558 B
Click the link below to download a spreadsheet with an example Revenue calculation for Novartis AG ADR below:

Sector Benchmark Analysis

All rights reserved. Terms Of Use